Osamu Kondoh

1.4k total citations
37 papers, 1.1k citations indexed

About

Osamu Kondoh is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Osamu Kondoh has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Osamu Kondoh's work include Lung Cancer Treatments and Mutations (6 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Osamu Kondoh is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Osamu Kondoh collaborates with scholars based in Japan, United States and Switzerland. Osamu Kondoh's co-authors include Tatsushi Kodama, Hiroshi Sakamoto, Miyuki Yoshida, Toshiyuki Tsukaguchi, Masami Hasegawa, Kenji Takanashi, Yuko Aoki, Yasuko Satoh, Mikio Arisawa and Yoshiaki Watanabe and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.

In The Last Decade

Osamu Kondoh

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Kondoh Japan 17 545 517 514 98 92 37 1.1k
Narmada Shenoy United States 11 532 1.0× 240 0.5× 299 0.6× 54 0.6× 57 0.6× 17 990
A. Kathleen McClendon United States 17 904 1.7× 937 1.8× 607 1.2× 152 1.6× 175 1.9× 20 1.6k
Zi-Jie Long China 23 797 1.5× 387 0.7× 145 0.3× 100 1.0× 120 1.3× 29 1.4k
Joseph R. Garlich United States 17 735 1.3× 210 0.4× 121 0.2× 115 1.2× 131 1.4× 33 1.1k
Martin L. Campbell United States 13 805 1.5× 515 1.0× 403 0.8× 68 0.7× 49 0.5× 18 1.4k
Benjamin A. Nacev United States 15 881 1.6× 322 0.6× 182 0.4× 35 0.4× 71 0.8× 34 1.2k
Beryl Hartley‐Asp Sweden 24 709 1.3× 514 1.0× 530 1.0× 63 0.6× 67 0.7× 71 1.6k
Shannon C. Dixon United States 14 452 0.8× 216 0.4× 222 0.4× 56 0.6× 31 0.3× 18 844
H.H. Sedlacek Austria 6 419 0.8× 393 0.8× 153 0.3× 86 0.9× 59 0.6× 7 737
Fumio Nakagawa Japan 20 381 0.7× 682 1.3× 299 0.6× 31 0.3× 78 0.8× 61 1.2k

Countries citing papers authored by Osamu Kondoh

Since Specialization
Citations

This map shows the geographic impact of Osamu Kondoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Kondoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Kondoh more than expected).

Fields of papers citing papers by Osamu Kondoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Kondoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Kondoh. The network helps show where Osamu Kondoh may publish in the future.

Co-authorship network of co-authors of Osamu Kondoh

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Kondoh. A scholar is included among the top collaborators of Osamu Kondoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Kondoh. Osamu Kondoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitsuhashi, Atsushi, Kazuya Koyama, Hirokazu Ogino, et al.. (2023). Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade. Cell Reports. 42(3). 112162–112162. 12 indexed citations
2.
Yamashita‐Kashima, Yoriko, Natsumi Kawasaki, Mitsue Kurasawa, et al.. (2022). Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors. International Journal of Hematology. 115(6). 860–872. 1 indexed citations
3.
Kawasaki, Natsumi, et al.. (2022). Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies. Molecular Biology Reports. 49(6). 4421–4433. 9 indexed citations
4.
Wakita, Daiko, et al.. (2021). PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion. Clinical & Experimental Metastasis. 39(2). 335–344. 2 indexed citations
5.
Iwai, Toshiki, Masamichi Sugimoto, Namrata S. Patil, et al.. (2021). Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab. Scientific Reports. 11(1). 13912–13912. 13 indexed citations
6.
Kodama, Tatsushi, Toshiyuki Tsukaguchi, Yasuko Satoh, et al.. (2015). Abstract 773: Alectinib shows potent antitumor activity against both ALK- and RET-rearranged non-small cell lung cancers. Cancer Research. 75(15_Supplement). 773–773. 1 indexed citations
7.
Kodama, Tatsushi, Toshiyuki Tsukaguchi, Yasuko Satoh, et al.. (2014). Alectinib Shows Potent Antitumor Activity against RET -Rearranged Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 13(12). 2910–2918. 125 indexed citations
8.
Kodama, Tatsushi, Toshiyuki Tsukaguchi, Miyuki Yoshida, Osamu Kondoh, & Hiroshi Sakamoto. (2014). Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance. Cancer Letters. 351(2). 215–221. 170 indexed citations
9.
Kodama, Tatsushi, et al.. (2014). Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases. Cancer Chemotherapy and Pharmacology. 74(5). 1023–1028. 200 indexed citations
10.
Ono, Naomi, Toshikazu Yamazaki, Yoshito Nakanishi, et al.. (2011). Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)‐overexpressing cancers. Cancer Science. 103(2). 342–349. 21 indexed citations
11.
Tanaka, Hiroshi, Miyuki Yoshida, Hiromi Tanimura, et al.. (2011). The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations. Clinical Cancer Research. 17(10). 3272–3281. 79 indexed citations
12.
Ohwada, Jun, Hirosato Ebiike, Hatsuo Kawada, et al.. (2011). Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799. Bioorganic & Medicinal Chemistry Letters. 21(6). 1767–1772. 56 indexed citations
13.
Asoh, Kohsuke, Tatsuo Ohtsuka, Miyako Masubuchi, et al.. (2009). Synthesis and structure–activity relationships of novel benzofuran farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1753–1757. 39 indexed citations
14.
Osaka, Shunzo, Osamu Kondoh, Yukihiro Yoshida, & Junnosuke Ryu. (2006). Radical excision of malignant sacral tumors using a modified threadwire saw. Journal of Surgical Oncology. 93(4). 312–317. 8 indexed citations
15.
Kondoh, Osamu, Tsuyoshi Takasuka, Mikio Arisawa, Yuko Aoki, & Takahide Watanabe. (2002). Differential Sensitivity between Fks1p and Fks2p against a Novel β-1,3-Glucan Synthase Inhibitor, Aerothricin1. Journal of Biological Chemistry. 277(44). 41744–41749. 11 indexed citations
16.
Murata, Takeshi, Masao Tsukazaki, Osamu Kondoh, et al.. (2001). Synthesis and Antifungal Activities of Novel 1,3-β-d-Glucan Synthase Inhibitors. Part 2. Bioorganic & Medicinal Chemistry Letters. 11(10). 1273–1276. 10 indexed citations
17.
Hamada, Kenji, Hiromichi Terashima, Osamu Kondoh, et al.. (1996). A point mutation within each of two ATP-binding motifs inactivates the functions of elongation factor 3. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1310(3). 303–308. 12 indexed citations
18.
19.
Tsukahara, Masato, et al.. (1994). Recombinant chromosome 18 resulting from a maternal pericentric inversion. American Journal of Medical Genetics. 50(4). 323–325. 29 indexed citations
20.
Matsuda, Yukihisa, et al.. (1991). Cardio‐Facio‐cutaneous (CFC) syndrome: Report of two patients without hyperkeratotic skin lesions. American Journal of Medical Genetics. 39(2). 144–147. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narmada Shenoy Breakdown of academic impact, for papers by A. Kathleen McClendon Breakdown of academic impact, for papers by Zi-Jie Long Breakdown of academic impact, for papers by Joseph R. Garlich Breakdown of academic impact, for papers by Martin L. Campbell Breakdown of academic impact, for papers by Benjamin A. Nacev Breakdown of academic impact, for papers by Beryl Hartley‐Asp Breakdown of academic impact, for papers by Shannon C. Dixon Breakdown of academic impact, for papers by H.H. Sedlacek Breakdown of academic impact, for papers by Fumio Nakagawa
Rankless by CCL
2026